tiprankstipranks
Advertisement
Advertisement

CGON Stock Latest News

JPMorgan ups CG Oncology target, adds ‘Positive Catalyst Watch’
The FlyJPMorgan ups CG Oncology target, adds ‘Positive Catalyst Watch’
22h ago
JNJ
CGON
CG Oncology price target raised to $84 from $72 at BofA
PremiumThe Fly
CG Oncology price target raised to $84 from $72 at BofA
4d ago
CGON
CG Oncology Appoints Veteran Jim DeTore as Chief Financial Officer
PremiumCompany Announcements
CG Oncology Appoints Veteran Jim DeTore as Chief Financial Officer
5d ago
8K
CGON
JPMorgan healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
JPMorgan healthcare analysts hold an analyst/industry conference call
9d ago
CGON
TARA
CG Oncology price target raised to $100 from $80 at H.C. Wainwright
PremiumThe Fly
CG Oncology price target raised to $100 from $80 at H.C. Wainwright
11d ago
CGON
CG Oncology price target raised to $90 from $60 at UBS
PremiumThe FlyCG Oncology price target raised to $90 from $60 at UBS
23d ago
CGON
Cretostimogene’s PIVOT‑6 Upside: Anticipated Superiority in Recurrence‑Free Survival Supports Buy on CG Oncology
Premium
Ratings
Cretostimogene’s PIVOT‑6 Upside: Anticipated Superiority in Recurrence‑Free Survival Supports Buy on CG Oncology
24d ago
CGON
CG Oncology price target raised to $72 from $65 at BofA
Premium
The Fly
CG Oncology price target raised to $72 from $65 at BofA
1M ago
JNJ
CGON
Buy Rating on CG Oncology Driven by PIVOT-006 Differentiation and 2026 Clinical, Regulatory Catalysts Supporting Favorable Risk–Reward
PremiumRatings
Buy Rating on CG Oncology Driven by PIVOT-006 Differentiation and 2026 Clinical, Regulatory Catalysts Supporting Favorable Risk–Reward
2M ago
CGON
CG Oncology: Advancing Creto Toward 2026 BLA with Pivotal PIVOT‑006 Catalyst and Expanding NMIBC Peak Sales Potential
PremiumRatings
CG Oncology: Advancing Creto Toward 2026 BLA with Pivotal PIVOT‑006 Catalyst and Expanding NMIBC Peak Sales Potential
2M ago
CGON
CG Oncology price target raised to $80 from $75 at H.C. Wainwright
PremiumThe Fly
CG Oncology price target raised to $80 from $75 at H.C. Wainwright
2M ago
CGON
CG Oncology reports FY25 EPS ($2.08), consensus (58c)
PremiumThe Fly
CG Oncology reports FY25 EPS ($2.08), consensus (58c)
2M ago
CGON
CG Oncology sees cash runway into 1H29
PremiumThe FlyCG Oncology sees cash runway into 1H29
2M ago
CGON
CG Oncology price target raised to $75 from $66 at Truist
Premium
The Fly
CG Oncology price target raised to $75 from $66 at Truist
2M ago
CGON
CG Oncology price target raised to $73 from $61 at RBC Capital
Premium
The Fly
CG Oncology price target raised to $73 from $61 at RBC Capital
3M ago
CGON
CG Oncology price target raised to $70 from $55 at Piper Sandler
PremiumThe Fly
CG Oncology price target raised to $70 from $55 at Piper Sandler
3M ago
CGON
Oncolytics appoints John McAdory as EVP, strategy and operations
PremiumThe Fly
Oncolytics appoints John McAdory as EVP, strategy and operations
3M ago
CGON
ONCY
CG Oncology Expands At-The-Market Equity Offering Capacity
PremiumCompany Announcements
CG Oncology Expands At-The-Market Equity Offering Capacity
3M ago
8K
CGON
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
AIM
CGON
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
3M ago
AIM
CGON
CG Oncology price target raised to $66 from $62 at Truist
Premium
The Fly
CG Oncology price target raised to $66 from $62 at Truist
3M ago
CGON
CG Oncology price target raised to $82 from $55 at Goldman Sachs
Premium
The Fly
CG Oncology price target raised to $82 from $55 at Goldman Sachs
3M ago
CGON

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >